Guidance for market authorization requirements for COVID-19 vaccines: Requirements for vaccines to address SARS-CoV-2 variants
We are collaborating with other national regulatory authorities to align the requirements for evaluating, authorizing and post-market surveillance of variant COVID-19 vaccines as much as possible.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2022-07-28
Data overview
- Formats
- HTML
- File languages
- English, French